Arbutus Biopharma (ABUS) Net Margin Growth (3y) (2016 - 2026)
Arbutus Biopharma (ABUS) Net Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - | 33,908.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33,908.00 |
| Dec 31, 2025 | -12,150.00 |
| Sep 30, 2025 | -116,610.00 |
| Jun 30, 2025 | 12,295.00 |
| Mar 31, 2025 | -126,528.00 |
| Dec 31, 2024 | -11,115.00 |
| Sep 30, 2024 | -74,699.00 |
| Jun 30, 2024 | -17,747.00 |
| Mar 31, 2024 | -24,676.00 |
| Dec 31, 2023 | -5,519.00 |
| Sep 30, 2023 | 99,860.00 |
| Jun 30, 2023 | 76,074.00 |
| Mar 31, 2023 | 88,504.00 |
| Dec 31, 2022 | 135,054.00 |
| Sep 30, 2022 | 249,136.00 |
| Jun 30, 2022 | 389,376.00 |
| Mar 31, 2022 | 369,885.00 |
| Dec 31, 2021 | 56,235.00 |
| Sep 30, 2021 | 97,795.00 |
| Jun 30, 2021 | -101,686.00 |